Write a short note on acute liver failure.
Definition
Acute liver failure (ALF, fulminant hepatic failure) is the development of severe acute liver injury with coagulopathy (INR ≥ 1.5) and hepatic encephalopathy in a patient without pre-existing liver disease, evolving within 26 weeks of the onset of illness.
Subclassification by the interval between jaundice and encephalopathy carries prognostic weight:
- Hyperacute (< 7 days) — typically paracetamol and viral hepatitis; highest rate of cerebral oedema but the BEST spontaneous survival
- Acute (8–28 days)
- Subacute (29 days–12 weeks) — less cerebral oedema but worst prognosis, often from drug injury and seronegative hepatitis
Aetiology
| Category | Causes |
|---|---|
| Viral (the commonest cause in India) | Hepatitis E (especially in pregnancy), hepatitis A, hepatitis B; hepatitis D superinfection; rarely herpes simplex, CMV, EBV |
| Drugs and toxins | PARACETAMOL (the commonest cause in the West); antitubercular drugs (isoniazid, rifampicin, pyrazinamide) — a major cause in India; halothane, valproate, phenytoin, NSAIDs; herbal and ayurvedic preparations; *Amanita phalloides* mushroom poisoning; carbon tetrachloride |
| Vascular | Budd–Chiari syndrome, ischaemic hepatitis (shock liver), veno-occlusive disease |
| Metabolic | Wilson's disease (with haemolysis and low ALP), acute fatty liver of pregnancy, Reye's syndrome |
| Others | Autoimmune hepatitis, malignant infiltration, heat stroke, sepsis, HELLP syndrome |
Clinical Features
- Jaundice, often deepening rapidly.
- HEPATIC ENCEPHALOPATHY — the defining feature, graded I to IV, with asterixis in early grades and coma in grade IV.
- Coagulopathy with bleeding — the INR is the key marker and must not be corrected prophylactically, as it is the main index of progression.
- CEREBRAL OEDEMA AND RAISED INTRACRANIAL PRESSURE — the leading cause of death in hyperacute failure: hypertension with bradycardia, abnormal pupillary responses, decerebrate posturing, and papilloedema (late).
- Hypoglycaemia — from failure of gluconeogenesis and glycogen depletion; profound and recurrent, and a frequent avoidable cause of death.
- Metabolic acidosis with hyperlactataemia; hyponatraemia, hypokalaemia, hypophosphataemia.
- Circulatory failure — vasodilated, hyperdynamic circulation resembling sepsis.
- Acute kidney injury — hepatorenal, acute tubular necrosis, or direct paracetamol nephrotoxicity.
- Sepsis — bacterial and fungal infection is very common, and fever and leucocytosis are often absent.
- Respiratory failure and ARDS; pancreatitis; adrenal insufficiency.
Investigations
- INR/prothrombin time and sensorium — the two measurements that must be repeated frequently; both determine prognosis and transplant listing.
- Liver function tests, glucose (hourly initially), arterial blood gas with lactate, ammonia, electrolytes, renal function, phosphate.
- Aetiological workup: paracetamol level, viral serology (anti-HAV IgM, HBsAg with anti-HBc IgM, anti-HEV IgM), autoantibodies and immunoglobulins, caeruloplasmin, serum and urinary copper, pregnancy test, toxicology, and Doppler ultrasound of hepatic veins for Budd–Chiari.
- CT head to exclude other causes of encephalopathy and assess cerebral oedema.
- Blood, urine and sputum cultures — surveillance cultures, given the frequency of occult sepsis.
Management
Acute liver failure is managed in an intensive care unit, ideally in a transplant centre — early transfer is essential and often left too late.
1. Specific therapy where available
- N-acetylcysteine — for paracetamol poisoning, and it also improves outcome in NON-paracetamol acute liver failure; give it early in all cases.
- Antivirals for hepatitis B; aciclovir for herpes; penicillin and silibinin for *Amanita*; chelation and consideration of transplant in Wilson's disease; urgent delivery in acute fatty liver of pregnancy and HELLP.
- Withdraw all hepatotoxic drugs.
2. Supportive care — the substance of management
- Neurological: nurse head-up at 30°, avoid stimulation, maintain normocapnia and normothermia (or mild hypothermia), hypertonic saline or mannitol for raised intracranial pressure; lactulose has limited evidence in ALF; sedation for grade III–IV; intubate and ventilate for grade III–IV encephalopathy.
- Metabolic: infuse dextrose continuously and check glucose hourly — hypoglycaemia is easily missed in a sedated patient; correct electrolytes and phosphate.
- Coagulopathy: do NOT correct the INR prophylactically — it is the principal prognostic marker and correcting it blinds you to the trend. Give vitamin K, and use plasma or factor concentrates only for active bleeding or before an invasive procedure.
- Infection: low threshold for empirical broad-spectrum antibiotics and antifungals, since sepsis precipitates deterioration and can preclude transplantation; surveillance cultures.
- Renal: avoid nephrotoxins; continuous renal replacement therapy (preferred over intermittent, for haemodynamic and intracranial stability).
- Circulatory: fluids and vasopressors; hydrocortisone for vasopressor-resistant hypotension.
- Nutrition: early enteral feeding with adequate protein — protein restriction is not indicated.
- Stress ulcer prophylaxis.
3. Liver transplantation — the definitive treatment
Refer EARLY to a transplant centre — before the patient becomes too unstable to transfer. Listing is guided by the King's College Criteria:
- Paracetamol-induced: arterial pH < 7.3 after resuscitation, OR the triad of INR > 6.5, creatinine > 3.4 mg/dL and grade III–IV encephalopathy; a raised arterial lactate is an additional early indicator.
- Non-paracetamol: INR > 6.5 alone, OR any three of: age < 10 or > 40 years, unfavourable aetiology (drug reaction, seronegative hepatitis), jaundice-to-encephalopathy interval > 7 days, INR > 3.5, bilirubin > 17.5 mg/dL.
Do not give fresh frozen plasma to "correct" the INR in acute liver failure unless the patient is bleeding or requires a procedure. The INR is the single most important prognostic variable and the basis of transplant listing; correcting it removes your ability to track the disease and can delay a life-saving referral. Equally, check the blood glucose hourly — recurrent hypoglycaemia in a sedated, encephalopathic patient is silent, common and lethal.
All questions in Hepatology / GIT
- Q1Discuss the aetiology, serology, clinical features, complications and management of viral hepatitis. ★
- Q2Discuss the aetiology, clinical features, complications, investigations and management of cirrhosis of the liver. ★
- Q3Discuss the causes, clinical assessment and management of upper gastrointestinal bleeding. ★
- Q4Discuss the aetiology, clinical features, severity assessment, complications and management of acute pancreatitis. ★
- SN1Write a short note on the approach to jaundice and interpretation of liver function tests.
- SN2Write a short note on acute liver failure.
- SN3Write a short note on non-alcoholic fatty liver disease and alcoholic liver disease.
- SN4Write a short note on portal hypertension and ascites.
- SN5Write a short note on hepatic encephalopathy.
- SN6Write a short note on hepatorenal syndrome.
- SN7Write a short note on spontaneous bacterial peritonitis and secondary peritonitis.
- SN8Write a short note on amoebiasis — intestinal and hepatic.
- SN9Write a short note on Wilson's disease.
- SN10Write a short note on the clinical approach to hepatomegaly and splenomegaly.
- SN11Write a short note on peptic ulcer disease, Helicobacter pylori and Zollinger-Ellison syndrome.
- SN12Write a short note on gastro-oesophageal reflux disease.
- SN13Write a short note on chronic diarrhoea and malabsorption.
- SN14Write a short note on inflammatory bowel disease.
- SN15Write a short note on acute infective diarrhoea — cholera and bacillary dysentery.
- SN16Write a short note on lower gastrointestinal bleeding.